Key result
Overt aggressivity and covert hostility are linked to distinct cardiovascular biomarker profiles in metabolic syndrome.
Why the study?
Do overt aggressivity and covert hostility correlate with specific cardiovascular risk biomarkers in patients with metabolic syndrome?
Cross-Sectional (n=101)
Yes
Do overt aggressivity and covert hostility correlate with specific cardiovascular risk biomarkers in patients with metabolic syndrome?
Overt aggressivity and covert hostility are associated with distinct cardiovascular risk biomarker profiles (lipid/obesity vs. cholesterol) in patients with metabolic syndrome.
May refine risk profiling in metabolic syndrome; leaves open causal links and interventional effects.
BACKGROUND: Recent studies have shown that different personality traits contribute to mortality in different subtypes of cardiovascular disease (CVD). Anger traits have been shown to promote the constellation of the metabolic syndrome (MetS), which in turn increases CVD risks. OBJECTIVE: To determine covariation of anger traits with CVD biomarkers, we examined patients (N = 101; 34 men and 67 women; age, 45.6 ± 13.96 years) in a nationally sampled treatment cohort for MetS in the Ukrainian governmental healthcare system. METHODS: Data collection was conducted in 2007. Laboratory data of single components of the MetS according to International Diabetes Federation Consensus were dependent measures in regression models with self-reported overt aggressivity and covert hostility in the Buss-Durkee Hostility Inventory and sociodemographic data. Structural equation models (SEMs) were tested. RESULTS: The SEM results are in favor of a sex-adjusted 2-factor solution R = 0.723), as indicated by equation-level Bentler-Raykov goodness-of-fit coefficients of 0.81 to 0.97 for paths to biological variables. Two latent components, 1 relating to aggressivity and the other to hostility, combine lipid/obesity-related measures and cholesterol-related measures, respectively. CONCLUSIONS: The SEM results suggest that CVD-risk biomarker variables in this MetS sample (a) associate into 2 distinct profiles and (b) that 1 profile associates with overt anger, whereas the other associates with covert hostility. These results could contribute to more personalized prevention and care in CVD patients.
No takes yet. Share an insight, caveat, or question.
Lemche et al. (2015) conducted a cross-sectional in Metabolic Syndrome (n=101). Anger traits (overt aggressivity and covert hostility) was evaluated on Covariation of anger traits with cardiovascular disease biomarkers (components of metabolic syndrome). Overt aggressivity and covert hostility were associated with distinct cardiovascular risk biomarker profiles in patients with metabolic syndrome (R2 = 0.723 for a sex-adjusted 2-factor solution).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: